Why physicians start or stop prescribing a drug: Literature review and formulary implications

Kent E.M. Groves, Priti S. Flanagan, Neil J. MacKinnon

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

The drug product life cycle is affected by factors that influence the diffusion of a new drug into medical practice and its rate of adoption and relinquishment by individual physicians. These influencing factors can be discussed in the context of four general categories: perceived attributes of new drug innovations, communication channels, nature of the social system, and physician characteristics. We report results of a literature search identifying studies that have assessed these factors' influence on drug diffusion, adoption, or relinquishment. We review the findings and specifically discuss how they can help formulary managers better align physician prescribing behavior with their organization's formulary objectives.

Original languageEnglish (US)
Pages (from-to)186-194
Number of pages9
JournalFormulary
Volume37
Issue number4
StatePublished - 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Why physicians start or stop prescribing a drug: Literature review and formulary implications'. Together they form a unique fingerprint.

Cite this